Can a smartwatch replace doctor visits for cancer patients?

NCT ID NCT05018208

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested whether a wearable device and smartphone app can monitor cancer patients' vital signs and symptoms as well as standard in-clinic checks. About 100 patients with various cancers participated, either after CAR-T cell therapy or during radiation treatment. The goal was to see if remote monitoring could detect problems like cytokine release syndrome or neurotoxicity, and to understand how often false alerts occur.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Wearable device and smartphone app
What this could lead to
If successful, this could show that remote monitoring is a reliable way to track cancer patients' health from home, potentially reducing hospital visits.
What could go wrong
This is a small, completed study focused on feasibility and accuracy, not on improving outcomes. The technology may not work as well as in-person assessments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.